Thomas Cunningham, OD
Optometrist · Chesterfield, MONPI 1053427104
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 30.4% of the total. Reporting peaked in 2019 at $682 and has fallen 51.3% since, to $332 in 2025.
Across 98 payments — averaging $27.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$833
- Johnson & Johnson Vision Care, Inc.$761
- Bausch & Lomb, A Division Of Bausch Health US, LLC$509
- Coopervision Inc.$235
- Alcon$168
- LKC Technologies, Inc.$146
- plus $89 from 4 others
What the payments were for
- Food & beverage$2,72399%
- Gifts$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 23 | $833 |
| Johnson & Johnson Vision Care, Inc. | 25 | $761 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 24 | $509 |
| Coopervision Inc. | 8 | $235 |
| Alcon | 12 | $168 |
| LKC Technologies, Inc. | 1 | $146 |
| ABB Con-cise Optical Group LLC | 2 | $32 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Menicon America Inc | 1 | $18 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,740 in reported general payments places this provider in the 80th percentile of 1,030 optometrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 15 | $140 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Chesterfield
- Sarah HubbardChesterfield$91K
- Patricia GelnerChesterfield$10K
- Kurt BennettChesterfield$10K
- Amber KoesterChesterfield$8K
- Julie HivelyChesterfield$8K
- Mindy RennardChesterfield$6K
- Andrew BiondoKirkwood$300K
- John McGrealSaint Louis$126K
- Alana KellerWildwood$94K
- Ariel CerenzieSaint Louis$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.